Shares in West Pharmaceutical Services (NYSE:WST) rose today after the company beat expectations on Wall Street with its third quarter results.
The Exton, Penn.-based company posted profits of $51 million, or 69¢ per share, on sales of $398.2 million for the 3 months ended Sept. 30, for bottom-line growth of 36% on sales growth of 6% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post West Pharma posts Street-beating Q3 earnings, sales appeared first on MassDevice.
from MassDevice http://ift.tt/2zFX020
Cap comentari:
Publica un comentari a l'entrada